ExLibris header image
SFX Logo
Title: Synthesis and in vitro evaluation of targeted tetracycline derivatives: Effects on inhibition of matrix metalloproteinases
Source:

Bioorganic & Medicinal Chemistry [0968-0896] Vidal, Aurélien yr:2007


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Iwata, T. "Effects of sodium hyaluronate on experimental osteoarthritis in rabbit knee joints." Nagoya journal of medical science 62.3-4 (1999): 115-26. Link to SFX for this item
2. Piecha D, D. "Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants." Inflammation Research 59.5 (2010): 379-389. Link to SFX for this item
3. Machado, Livia S S. "Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke." BMC neuroscience 7.1 (2006): 56-. Link to Full Text for this item Link to SFX for this item
4. Curtright, C. "A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas." Investigational new drugs 25.4 (2007): 359-67. Link to Full Text for this item Link to SFX for this item
5. Bartlett, Derek W. "Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles." Bioconjugate chemistry 18.2 (2007): 456-468. Link to Full Text for this item Link to SFX for this item
6. Fisher, Jed F F. "Recent advances in MMP inhibitor design." Cancer and metastasis reviews 25.1 (2006): 115-36. Link to Full Text for this item Link to SFX for this item
7. Leblond, J. "Lipopolythioureas: A new non-cationic system for gene transfer." Bioconjugate chemistry 18.2 (2007): 484-493. Link to Full Text for this item Link to SFX for this item
8. Teeguarden, Justin G G. "Particokinetics in vitro: Dosimetry considerations for in vitro nanoparticle toxicity assessments." Toxicological Sciences 95.2 (2006): 300-312. Link to SFX for this item
9. Jeong, Ji H. "Reducible poly(amido ethylenimine) directed to enhance RNA interference." Biomaterials 28.10 (2007): 1912-1917. Link to SFX for this item
10. Moore, A. "In vivo imaging of siRNA delivery and silencing in tumors." Nature medicine 13.3 (2007): 372-377. Link to Full Text for this item Link to SFX for this item
11. Christiaens, B. "Enhancement of polymethacrylate-mediated gene delivery by penetratin." European journal of pharmaceutical sciences 24.5 (2005): 525-537. Link to SFX for this item
12. Laznicek, M. "Preclinical pharmacokinetics of radiolabelled hyaluronan." Pharmacological Reports 64.2 (2012): 428-37. Link to SFX for this item
13. French, H. Rheumatology 50.suppl_3 (2011): 14-14. Link to SFX for this item
14. Rowinsky, Eric K K. "Lately, it occurs to me what a long, strange trip it's been for the farnesyltransferase inhibitors." Journal of clinical oncology 24.19 (2006): 2981-4. Link to SFX for this item
15. Kitabayashi, C. "Zinc suppresses Th17 development via inhibition of STAT3 activation." International Immunology 22.5 (2010): 375-386. Link to SFX for this item
16. Madsen, Suzi H. "Aggrecanase- and matrix metalloproteinase-mediated aggrecan degradation is associated with different molecular characteristics of aggrecan and separated in time ex vivo." Biomarkers 15.3 (2010): 266-276. Link to SFX for this item
17. Huh, J. "Efficacy and mechanism of action of KHBJ-9B, a new herbal medicine, and its major compound triterpenoids in human cartilage culture and in a rabbit model of collagenase-induced osteoarthritis." International immunopharmacology 9.2 (2009): 230-240. Link to SFX for this item
18. Chanhung Z Lee Jianhua S Yao Yong Huang Wenwu Zhai, William L. "Dose–response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation." Journal of cerebral blood flow and metabolism 26.9: 1157-1164. Link to SFX for this item
19. Polee, M. "A phase I and pharmacokinetic study of temsirolimus (CCI-779) administered intravenously daily for 5 days every 2 weeks to patients with advanced cancer." Clinical cancer research 12.19 (2006): 5755-4490. Link to SFX for this item
20. Chang, Dae-Il I. "Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia." Journal of cerebral blood flow and metabolism 23.12 (2003): 1408-19. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced